Publications by authors named "Michael Roguska"

Claim this Profile
T
Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria.
Jun-Ichi Nishimura, Kiyoshi Ando, Masayoshi Masuko, Hideyoshi Noji, Yoshikazu Ito, Michael Roguska

Haematologica· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting protein drugs for the treatment of ocular diseases.
Joy G Ghosh, Andrew A Nguyen, Chad E Bigelow, Stephen Poor, Yubin Qiu, Michael Roguska

Nat Commun· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview on the use of therapeutic antibodies in drug discovery.
Michael Roguska, Zehra Kaymakcalan, Jochen Salfeld

Curr Protoc Pharmacol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis